Anti-EGFR antibodies also induce antibody-dependent cellular cytotoxicity, facilitating immune cell cross-talk, allowing for tumor-antigen-specific cellular immunity and the development of antigen-specific T-lymphocyte responses. This evidence concerns the gene EGFR and neoplasm.